STO Equity Snapshot
ACTI Weekly Equity Report
Active Biotech AB (publ)
What the company does
Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematological malignancies; Laquinimod, an immunomodulator for the treatment of severe inflammatory eye diseases, such as non-infectious non anterior uveitis; and Naptumomab estafenatox, a tumor targeting immunotherapy to treat patients with solid tumors. The company has collaboration with Abramson Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, Texas and Stictching-Haemato-Oncologie Volwassenen Netherlands, as well …
What the weekly tape is saying
ACTI closed the latest completed week at 6.12 SEK. The 4-week return is -7.0% and the 12-week return is 14300.0%. Trend Signal is active, Market Dynamics is 0.50. Setup signature: Deep recovery attempt with a 54/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 2.41 SEK
- Vs Trend Line
- 153.5%
- Fair Value
- 0.78 SEK
- Vs Fair Value
- 680.1%
- 52W High
- 9.43 SEK
- 52W Low
- 0.04 SEK
- Drawdown
- -35.1%
- Range Position
- 64.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 11 weeks
- 52W Active Weeks
- 27
- 52W Active Breadth
- 51.9%
- Sector Scope
- SE Healthcare
- Sector Rank
- 136 of 158
- Sector Percentile
- 14.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- 77 of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Biotechnology
- Tracked Peers
- 59
- 4W Rank
- 37 of 59
- Avg 1W
- 3.1%
- Avg 4W
- -1.6%
- Trend Breadth
- 30.5%
- Positive RS
- 22.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.50
- 4W MD Change
- -40.3%
- Relative Strength
- 312.12
- 4W RS Change
- -45.1%
- Expectation
- Negative
- Probability
- 42.61%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 759.2K
- 13W Average
- 9.0M
- 52W Average
- 37.8M
- Vs 13W
- 0.1x
- Vs 52W
- 0.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4230.8%
- 52W Volatility
- 2180.9%
- Upside Weeks
- 21
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 763.5% / -10.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- SEK
- Market Cap
- 163.4M
Opportunity signals
- Trend Signal is active with a 11-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
- Recent volatility is running well above the one-year baseline.
- Latest weekly return ranks in the weaker part of its sector group.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 6.12 SEK | -8.7% | 2.41 SEK | 0.78 SEK | 0.50 | 312.12 | 759.2K | On |
| 5 Jun 2026 | 6.71 SEK | 6.8% | 2.21 SEK | 0.75 SEK | 0.62 | 387.87 | 1.5M | On |
| 29 May 2026 | 6.28 SEK | -11.3% | 1.99 SEK | 0.71 SEK | 0.69 | 398.75 | 821.1K | On |
| 22 May 2026 | 7.08 SEK | 7.6% | 1.78 SEK | 0.68 SEK | 0.79 | 515.94 | 2.8M | On |
| 15 May 2026 | 6.58 SEK | 17.1% | 1.55 SEK | 0.64 SEK | 0.84 | 568.93 | 614.5K | On |
| 8 May 2026 | 5.62 SEK | -7.3% | 1.34 SEK | 0.60 SEK | 0.89 | 545.58 | 753.4K | On |
| 1 May 2026 | 6.06 SEK | -8.7% | 1.16 SEK | 0.57 SEK | 0.93 | 695.94 | 538.5K | On |
| 24 Apr 2026 | 6.64 SEK | -10.3% | 0.96 SEK | 0.53 SEK | 0.93 | 913.25 | 2.4M | On |
| 17 Apr 2026 | 7.40 SEK | 21.3% | 0.74 SEK | 0.50 SEK | 0.83 | 1261.27 | 2.3M | On |
| 10 Apr 2026 | 6.10 SEK | -12.2% | 0.50 SEK | 0.46 SEK | 0.71 | 1445.54 | 1.8M | On |
| 3 Apr 2026 | 6.95 SEK | 15877.0% | 0.30 SEK | 0.42 SEK | 0.59 | 2509.71 | 4.0M | On |
| 27 Mar 2026 | 0.04 SEK | 2.4% | 0.08 SEK | 0.38 SEK | 0.59 | -66.50 | 56.1M | Off |
| 20 Mar 2026 | 0.04 SEK | 2.9% | 0.08 SEK | 0.39 SEK | 0.71 | -67.57 | 42.6M | Off |
| 13 Mar 2026 | 0.04 SEK | -5.7% | 0.09 SEK | 0.39 SEK | 0.83 | -70.35 | 81.1M | Off |